Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...
Randian, which contributed to the retail activist campaign behind Opendoor Technologies Inc (NASDAQ:OPEN), has been publicly ...
New research from the University of St Andrews has found that some coastal areas will become much more acidic than previously anticipated. With added atmospheric CO2, these areas are acidifying more ...
KRRO-110 produced functional protein in Alpha-1 Antitrypsin Deficiency (AATD) patients —KRRO-110 did not reach projected levels of functional protein following a single administration —Pivoting to ...
From medicine to agriculture and aquaculture, bacteriophages are poised to have a huge global impact. As viruses which target ...
Investing.com -- CytomX Therapeutics Inc (NASDAQ:CTMX) stock gained 4% Tuesday following the announcement that initial translational data from its Phase 1 study of CX-801 in advanced melanoma patients ...
CAMBRIDGE, Mass., Oct. 31, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and inflammation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback